Health Care
Group Leader


Eric M. Huebscher
Director
Cell: 917-763-3891
FAX: 212-202-3503

Download V Card

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Health Care Services Group

Overview of Experience In the healthcare industry

NHB Advisors, Inc. focuses on the creation of value, the preservation of capital through operational improvements. In addition, NHB Advisors, Inc. provides a resource for turnaround and crisis management, corporate board participation, operational oversight, fund advisory, expert witness testimony and fiduciary and post-confirmation management.

  • NHB Advisors, Inc. turnaround services include assessment of business viability and available turnaround strategies, implementation of turnaround strategies, assessment of financing and organizational resources and recommendations.

  • NHB Advisors, Inc. operational oversight services include monitoring and reporting on
    collateral tracking issues, fraud and challenging circumstances faced by
    middle market companies.

  • NHB Advisors, Inc. fund advisory services include sourcing deals, front-end work and
    monitoring and management of portfolio companies and acquisitions.

Health Care Engagements

  • Financial Advisor to the Official Committee of Unsecured Creditors in Senior Management Services, et al., an operator of skilled nursing facilities.

  • Financial Advisor to a $50 Million nursing home chain, engaged to provide leadership and advisory services.

  • Financial Advisor to Nursing Home Operator with 200 owned or managed facilities.

  • Financial Advisor to Beckett Healthcare, a provider of on-site/in-home healthcare and
    rehabilitation services.

  • Financial Advisor to Legend Healthcare, national provider of contract services to regional healthcare providers.

  • Chief Restructuring Officer at InterPharm, a publicly held generic drug manufacturer.

  • Financial advisor at privately-held generic drug manufacturer and distribution.

  • Financial Advisor to RML Labs, a clinical laboratory and provider of special
    analytical services.

  • Financial Advisor to Enzymatics, a biotechnology and in-vitro diagnostics company.

  • Financial Advisor to Cytogen, a specialty pharmaceutical developer of oncology products.

  • Financial Advisor to RML Labs, a clinical laboratory and provider of special
    analytical services.

  • Financial Advisor to Enzymatics, a biotechnology and in-vitro diagnostics company.

  • Financial Advisor to the Official Committee of Unsecured Creditors in Aphton BioPharma,
    a specialty pharmaceutical developer of cancer treatment and gastrointestinal therapies.

  • Financial Advisor to the Official Committee of Unsecured Creditors in World Health
    Alternatives, a medical staffing company.

  • Financial Advisor to a distributor of pharmaceuticals and health/beauty aids to drug
    stores and drug store chains.